Rimonabant for Neurocognition in Schizophrenia: A 16-Week Double Blind Randomized Placebo Controlled Trial

OBJECTIVE: To examine the effect of rimonabant on neurocognitive impairments in people with schizophrenia. METHODS: Participants entered a 16-week double-blind, placebo-controlled, randomized clinical trial. A neurocognitive battery was administered at baseline and end of study. RESULTS: In comparis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boggs, Douglas L., Kelly, Deanna L., McMahon, Robert P., Gold, James M., Gorelick, David A., Linthicum, Jared, Conley, Robert R., Liu, Fang, Waltz, James, Huestis, Marilyn A., Buchanan, Robert W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3268840/
https://ncbi.nlm.nih.gov/pubmed/22137462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2011.11.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados